IDEXX Laboratories Announces Second Quarter Results

Go back to IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories (IDXX) PT Raised to $700 at Stifel

July 30, 2021 1:36 PM EDT

Stifel analyst Jonathan D. Block raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $700.00 (from $600.00) while maintaining a Buy rating following results.

The analyst commented, "IDEXX reported another exceptional quarter with revenue/EPS upside, and management solidly raised 2021 guidance (details below). Importantly,... More

IDEXX Labs (IDXX) Tops Q2 EPS by 30c; Raises Outlook

July 30, 2021 6:36 AM EDT

IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $2.34, $0.30 better than the analyst estimate of $2.04. Revenue for the quarter came in at $826 million versus the consensus estimate of $782.99 million.

GUIDANCE:

IDEXX Labs sees FY2021 EPS of $8.20-$8.36, versus the consensus of... More